UMR-106 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | UMR-106 is an osteosarcoma cell line derived from a rat model, commonly used in studies investigating bone metabolism, cancer biology, and osteoblast differentiation. These cells are highly responsive to parathyroid hormone (PTH), prostaglandins, and bone-resorbing steroids, making them valuable for research on the regulatory mechanisms of bone cells. The PTH responsiveness of UMR-106 cells is notably greater than that of the related cell line UMR-108, highlighting their unique utility in studies focused on PTH signaling pathways. UMR-106 cells also exhibit the production of alkaline phosphatase, osteocalcin, and other bone-related proteins, which are critical markers in osteoblast research. In cancer research, UMR-106 cells serve as a model to study the molecular mechanisms underlying osteosarcoma development and progression. They exhibit typical features of cancer cells, such as rapid proliferation and the ability to form tumors in vivo, allowing researchers to explore the genetic and epigenetic changes associated with osteosarcoma. These cells are also instrumental in preclinical studies for testing the efficacy and safety of new anti-cancer drugs, providing a reliable system for the preliminary evaluation of therapeutic agents. Furthermore, UMR-106 cells are utilized to investigate the pathways involved in osteoblast function and differentiation. Researchers have observed that activation of protein kinase C in UMR-106 cells inhibits ATP-induced increases in intracellular calcium levels, providing insights into the complex regulatory networks governing osteoblast activity. The responsiveness of these cells to various stimuli, along with their ability to produce key osteoblastic markers, makes UMR-106 a critical tool in the study of bone biology and the development of strategies to treat bone-related disorders. |
|---|---|
| Organism | Rat |
| Tissue | Bone |
| Disease | Rat osteosarcoma |
| Synonyms | UMR 106, UMR106 |
Characteristics
| Breed/Subspecies | Sprague Dawley |
|---|---|
| Age | Adult |
| Morphology | Epithelial |
| Growth properties | Adherent |
Regulatory Data
| Citation | UMR-106 (Cytion catalog number 305197) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10116 |
| CellosaurusAccession | CVCL_3617 |
Biomolecular Data
| Receptors expressed | Parathyroid hormone(PTH), 1-25(OH)2D3(bone resorbing steroid hormone) |
|---|
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|